| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.66▼ | 1.67▼ | 1.67▼ | 1.85▼ | 1.84▼ |
| MA10 | 1.67▼ | 1.67▼ | 1.68▼ | 1.86▼ | 1.35▲ |
| MA20 | 1.68▼ | 1.68▼ | 1.74▼ | 1.82▼ | 1.08▲ |
| MA50 | 1.67▼ | 1.80▼ | 1.89▼ | 1.28▲ | 1.10▲ |
| MA100 | 1.69▼ | 1.89▼ | 1.81▼ | 1.05▲ | 3.14▼ |
| MA200 | 1.78▼ | 1.81▼ | 1.76▼ | 0.96▲ | 10.61▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.007▲ | -0.002▼ | -0.054▼ | 0.154▲ |
| RSI | 36.844▼ | 30.707▼ | 31.513▼ | 49.561▼ | 58.513▲ |
| STOCH | 15.278▼ | 38.704 | 16.147▼ | 49.399 | 75.493 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -82.759▼ | -35.429 |
| CCI | -161.905▼ | -122.730▼ | -104.195▼ | -74.509 | 78.024 |
| RSI | $PALI RSI(14) Crossed Below 50 | Set Alert |
|
Tuesday, October 28, 2025 08:13 AM
Inc. (Nasdaq: PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing precision therapies for autoimmune, inflammatory, and fibrotic diseases, today announced the ...
|
|
Tuesday, October 28, 2025 06:00 AM
Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications Company remains focused on ...
|
|
Tuesday, October 28, 2025 05:50 AM
Palisade Bio (PALI) announced the appointment of Sharon Skare as Vice President, Global Head of Clinical Operations. Skare most recently served as ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/25 | 1.69 | 1.78 | 1.645 | 1.66 | 1,642,784 |
| 05/11/25 | 1.80 | 1.84 | 1.655 | 1.68 | 3,861,120 |
| 04/11/25 | 1.91 | 1.9703 | 1.8004 | 1.84 | 2,123,163 |
| 03/11/25 | 1.99 | 2.03 | 1.765 | 2.00 | 6,372,747 |
| 31/10/25 | 1.99 | 2.09 | 1.92 | 2.07 | 4,933,576 |
| 30/10/25 | 2.00 | 2.11 | 1.92 | 1.94 | 5,435,361 |
| 29/10/25 | 1.88 | 2.14 | 1.88 | 2.12 | 12,671,361 |
| 28/10/25 | 1.67 | 1.8699 | 1.64 | 1.85 | 6,223,816 |
| 27/10/25 | 1.72 | 1.74 | 1.61 | 1.66 | 2,785,088 |
| 24/10/25 | 1.74 | 1.77 | 1.6936 | 1.74 | 2,276,146 |
|
|
||||
|
|
||||
|
|